Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00200122 · ClinicalTrials.gov registry record · Phase 4
Restore Claims Characterization Study
A Phase 4 study of Chronic Refractory Pain Associated With Failed Back Surgery Syndrome, Epidural Fibrosis, Peripheral Causalgia, Complex Regional Pain Syndrome, sponsored by MedtronicNeuro.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 8
- Study locations
NCT00200122: Completed Phase 4 study of Chronic Refractory Pain Associated With Failed Back Surgery Syndrome, Epidural Fibrosis, Peripheral Causalgia, Complex Regional Pain Syndrome, sponsored by MedtronicNeuro.
NCT00200122 is a Phase 4 study of Chronic Refractory Pain Associated With Failed Back Surgery Syndrome, Epidural Fibrosis, Peripheral Causalgia, Complex Regional Pain Syndrome that has completed, run by MedtronicNeuro. The registered enrollment target is 100 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower). The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00200122, a Phase 4 study of Chronic Refractory Pain Associated With Failed Back Surgery Syndrome, Epidural Fibrosis, Peripheral Causalgia, Complex Regional Pain Syndrome, has completed, sponsored by MedtronicNeuro.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 8
- Study locations
Study Summary
The purpose of this study is to characterize the pain coverage capability of the RESTORE spinal cord stimulation (SCS) and assess health outcomes.
Conditions Studied
Interventions
- DEVICE Spinal Cord Stimulation
Study Locations (8)
Texas
- Contact Medtronic for Exact Location - Dallas
- Contact Medtronic for Exact Location - San Antonio
Illinois
- Contact Medtronic for Exact Location - Chicago
Indiana
- Contact Medtronic for Exact Location - Indianapolis
Missouri
- Contact Medtronic for Exact Location - Kansas City
New York
- Contact Medtronic for Exact Location - Syosset
Oregon
- Contact Medtronic for Exact Location - Eugene
West Virginia
- Contact Medtronic for Exact Location - Huntington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2005-01 |
| Est. Completion | 2007-08 |
| Phase | Phase 4 |
What the finished NCT00200122 record still lists
NCT00200122 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Chronic Refractory Pain Associated With Failed Back Surgery Syndrome, Epidural Fibrosis, Peripheral Causalgia, Complex Regional Pain Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Spinal Cord Stimulation is the first listed.
NCT00200122 lists 8 locations in 7 states (Texas, Illinois, Indiana).
Frequently Asked Questions
What is clinical trial NCT00200122 about?
NCT00200122 is a clinical study titled "Restore Claims Characterization Study". The purpose of this study is to characterize the pain coverage capability of the RESTORE spinal cord stimulation (SCS) and assess health outcomes.
What is the current status of trial NCT00200122?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2005-01. Estimated completion is 2007-08.
What conditions does trial NCT00200122 study?
This clinical trial studies the following conditions: Chronic Refractory Pain Associated With Failed Back Surgery Syndrome, Epidural Fibrosis, Peripheral Causalgia, Complex Regional Pain Syndrome.
What interventions are being tested in trial NCT00200122?
The interventions under investigation include: Spinal Cord Stimulation (DEVICE).
Who is sponsoring clinical trial NCT00200122?
This trial is sponsored by MedtronicNeuro, which has 51 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00200122 being conducted?
This trial has 8 study locations across Illinois, Indiana, Missouri, New York, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00200122's enrollment target sits among peer trials
100 770th of 2000 higher than 1,149 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia